Back to top

THIRD AMENDMENT TO EMPLOYMENT AGREEMENT

Employment Agreement

THIRD AMENDMENT TO EMPLOYMENT AGREEMENT | Document Parties: ACURA PHARMACEUTICALS, INC You are currently viewing:
This Employment Agreement involves

ACURA PHARMACEUTICALS, INC

. RealDealDocs™ contains millions of easily searchable legal documents and clauses from top law firms. Search for free - click here.
Title: THIRD AMENDMENT TO EMPLOYMENT AGREEMENT
Governing Law: New York     Date: 7/10/2008
Industry: Biotechnology and Drugs     Sector: Healthcare

THIRD AMENDMENT TO EMPLOYMENT AGREEMENT, Parties: acura pharmaceuticals  inc
50 of the Top 250 law firms use our Products every day
 
Exhibit 10.2

THIRD AMENDMENT TO EMPLOYMENT AGREEMENT

THIS THIRD AMENDMENT TO EMPLOYMENT AGREEMENT (this “ Amendment ”) made this 9 th day of July, 2008 by and between ACURA PHARMACEUTICALS, INC. , a New York corporation (the “ Corporation”) and RON J. SPIVEY (the “ Employee ”).

R E C I TA L S

A.  
The Corporation and the Employee executed an employment agreement dated as of April 5, 2004, which was subsequently amended (as amended, the “ Employment Agreement ”).
   
B.  
The Corporation and the Employee now desire to further amend the Employment Agreement as provided herein to provide (i) for a bonus payment to Employee provided he remains employed by the Corporation through December 31, 2008 and (ii) at Employee’s request, for a reduction in Employee’s duties to the Corporation during the period January 1, 2009 through December 31, 2010.

NOW, THEREFORE , in consideration of the mutual covenants and undertakings herein contained, the parties agree as follows:

1.    A new Section 3(c) is added to the Agreement as follows:

“(c) Retention Bonus. If Employee remains as a full-time employee with the Corporation through December 31, 2008 then he shall be entitled to a one-time bonus payment of Three Hundred Fifteen Thousand Dollars ($315,000) (the “Bonus Payment”), payable by the Corporation to the Employee on December 31, 2008. If Employee ceases to be a full-time employee for any reason prior to December 31, 2008, then he shall not be entitled to the Bonus Payment; provided , however , that the Bonus Payment will remain payable if the Employee’s employment is terminated (i) by the Corporation (or its successor) without Cause or following a Change of Control, or (ii) by the Employee for Good Reason.

2.    Effective January 1, 2009, assuming Executive’s employment with the Corporation has not terminated prior thereto, the Agreement shall be further amended and replaced in its entirety effective as of such date by the Amended and Restated Employment Agreement attached hereto as Exhibit A . During the period through December 31, 2008, the Employment Agreement, as amended by this Amendment, shall govern the employment relationship between the Corporation and Employee. Commencing January 1, 2009, the Amended and Restated Employment Agreement, attached hereto as Exhibit A , shall govern the employment relationship between the Corporation and Employee.

3.    Except as expressly amended by this Amendment, the Employment Agreement remains in full force and effect. Capitalized terms used herein shall have the same meaning as in the Employment Agreement unless otherwise defined herein. This Amendment shall be governed and construed and enforced in accordance with the local laws of the State of New York applicable to agreements made and to be performed entirely in New York.
 
Page 1 of 10

 
4.    This Amendment may be executed in one or more facsimile or original counterparts, each of which shall be deemed an original, but all of which taken together will constitute one and the same instrument.


IN WITNESS WHEREOF , the parties have executed this Amendment as of the date first above written.
 
ACURA PHARMACEUTICALS, INC.
 
By: /s/ Andrew D. Reddick            
Andrew D. Reddick
President and Chief Executive Officer
 
 
EMPLOYEE
 
By: /s/ Ron J. Spivey                  
Ron J. Spivey


Page 2 of 10


EXHIBIT A
 
AMENDED AND RESTATED EMPLOYMENT AGREEMENT

This AMENDED AND RESTATED EMPLOYMENT AGREEMENT (the " Agreement ") effective as of the 1st day of January, 2009 (the “Effective Date”) by and between ACURA PHARMACEUTICALS, INC. , a New York corporation (the " Corporation "), with administrative offices at 616 N. North Court, Suite 120, Palatine, IL 60067 and RON J. SPIVEY , residing at 3514 Bimini Avenue, Cooper City, Florida 33026   (the " Employee ").

W I T N E S S E T H
WHEREAS , Employee has been employed by the Corporation pursuant to an Executive Employment Agreement dated as of April 5, 2004, as amended (the “Original Agreement”); and
 
WHEREAS , the Employee desires to reduce his role with the Corporation commencing January 1, 2009; and
 
WHEREAS , the parties hereto have agreed to amend and restate the Original Agreement, as provided herein;
 
NOW, THEREFORE , in consideration of the mutual covenants and undertakings herein contained, the parties agree as follows:
 
1.        Employment, Duties and Acceptance .
 
1.1     Services . Commencing on the Effective Date the Corporation shall continue the employment of the Employee pursuant to the terms of this Agreement for the Term (as defined in Section 2 hereof), to render services to the Corporation of ten (10) weeks per year, at such times as mutually agreed by the Corporation's Chief Executive Officer ("CEO") and the Employee, as the Corporation's Senior Scientific Advisor, subject to the direction of the CEO and the Corporation's Board of Directors. In connection therewith, the Employee shall assist and advise the Corporation with the development of product candidates and such other tasks as may be further reasonably be requested to be performed by the CEO, to whom the Employee shall report, and to use his commercially reasonable best efforts, skill and abilities to promote the interests of the Corporation and its subsidiary. The Employee shall perform the services for the Corporation from his home office and by traveling to the Corporation's facilities and such other locations as shall be agreed by the Employee and CEO from time to time, including, without limitation, the locations of contract research organizations, clinical trial sites, and other locations required for meetings or presentations with prospective investors, counsel, prospective pharmaceutical partners and other locations as the CEO shall determine to be in the best business interests of the Corporation. The Employee acknowledges and agrees that the change in the Employee’s title, reduction in responsibilities, service hours, and compensation is being effected at the request of the Employee and will not constitute or be deemed grounds for the Employee’s “Good Reason” termination as provided in Section 7.5 of the Original Agreement.
 
Page 3 of 10

 
1.2     Acceptance . The Employee hereby accepts the terms of continued employment with the Corporation and commencing on the Effective Date, and agrees to render the services described in Section 1.1 hereof.
 
2.       Term of Employment . The term of the Employee’s employment under this Agreement shall commence on the Effective Date and shall expire on December 31, 2010 (the “ Term ”), unless sooner terminated pursuant to Section 7 of this Agreement.
 
3.       Compensation . In consideration of the services to be rendered by the Employee pursuant to this Agreement, the Corporation shall pay the Employee an aggregate annual base salary of One Hundred Twenty Thousand Dollars ($120,000) (the " Base Salary "), payable in equal weekly installments in accordance with the Corporation’s customary payroll practices, less such deductions or amounts to be withheld as required by applicable laws and regulations.
 
4.       Expenses . The Corporation shall pay or reimburse the Employee for all reasonable expenses which are incurred in accordance with the Corporation’s expense policy in force from time to time and which are actually incurred or paid by the Employee during the Term in the performance of his services under this Agreement, upon presentation of expense statements or vouchers or such other supporting information as the Corporation may reasonably require. Such expenses shall include, but not be limited to, business travel, travel to corporate facilities and related temporary living expenses, meals and lodging, and business entertainment.
 
5.       Additional Benefits . In addition to the compensation and expenses to be paid under Sections 3 and 4 hereof, the Employee will be entitled to such rights and benefits for which he may be eligible (as a part time employee) under any insurance or retirement plan of the Corporation as the Board of Directors shall adopt from time to time in its sole and absolute discretion for the benefit of employees of the Corporation.
 
Page 4 of 10

 
6.       Stock Options/Restricted Stock Units . The Employee and the Corporation acknowledge and agree that the stock options and restricted stock unit awards issued to the Employee by the Corporation as of the date of this Agreement shall remain in full force and effect and the Employee’s right to exercise such stock options and to receive distributions under such restricted stock units shall be as provided in the respective award agreements and the plans pursuant to which such stock options and restricted stock unit awards were issued; provided, however, that with respect to the stock options granted to the Employee on May 23, 2008 exercisable for up to 160,000 shares of the Corporation’s common stock, in the event of the termination of the Employee’s employment (a) by the Employee, the Employee may exercise such options to the extent vested at the

 
SITE SEARCH

AGREEMENTS / CONTRACTS

Document Title:

Entire Document: (optional)

Governing Law:(optional)


Try our advanced search >>
 

CLAUSES

Search Contract Clauses >>

Browse Contract Clause Library>>

Get Email Updates
Email:
This is only a partial view of this document. We have millions of legal documents and clauses drafted by top law firms. learn more search for free browse for free learn more